Role of HSP90-alpha in preserving immunoprivilege of allogenic mesenchymal stem cells in the ischemic heart
Role of HSP90-alpha in preserving immunoprivilege of allogenic mesenchymal stem cells in the ischemic heart
批准号:
370541
负责人:
Dhingra Sanjiv
金额:
$54.62万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2017
资助国家:
加拿大
项目状态:
已结题
起止时间:
2017-09-01 至 2022-09-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Heart disease is one of the leading causes of death in Canada. Unfortunately, there are no effective therapies available that can provide permanent solution to the problem. Identifying, new research approaches that can offer permanent therapies for this d
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Determinants of immunogenicity of allogeneic mesenchymal stem cells in the ischemic heart
-
批准号:478259
-
项目类别:Operating Grants
-
资助金额:$74.87万
-
财政年份:2023
-
负责人:Dhingra Sanjiv
-
依托单位:
Role of COP 9 signalosome subunit 5 in preserving immunoprivilege of allogeneic mesenchymal stem cells in the ischemic heart
-
批准号:444561
-
项目类别:Operating Grants
-
资助金额:$69.94万
-
财政年份:2021
-
负责人:Dhingra Sanjiv
-
依托单位:
Preserving the immunoprivilege of transplanted allogeneic mesenchymal stem cells in the ischemic heart
-
批准号:321665
-
项目类别:Operating Grants
-
资助金额:$37.97万
-
财政年份:2015
-
负责人:Dhingra Sanjiv
-
依托单位:
海外基金